Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; Therapeutic perspectives

Journal of Perinatal Medicine

Volumn 24, Issue 2, 1996, Pages 119-139

  Dekker, Gustaaf A ^a   Van Geijn, Herman P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antiphospholipid; Endothelium; Glycoprotein IIB IIIa; Homocysteinemia; Nitric oxide; Platelet; Preeclampsia; Prostacyclin; Protein S; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BERAPROST; CICAPROST; CLOPIDOGREL; CYCLO(DEXTRO 2 AMINOBUTYRYL 2 N METHYLARGINYLGLYCYLASPARTYL 3 AMINOMETHYLBENZOIC ACID) METHANESULFONATE; DAZOXIBEN; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; FISH OIL; GLYCERYL TRINITRATE; HIRUDIN; ILOPROST; MONOCLONAL ANTIBODY; NAFAZATROM; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PENTOXIFYLLINE; PICOTAMIDE; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; RIDOGREL; THROMBIN RECEPTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR; TICLOPIDINE; UNINDEXED DRUG; ZAPRINAST;

ANTICOAGULATION; CLINICAL TRIAL; ENDOTHELIUM CELL; GASTROINTESTINAL SYMPTOM; HOMOCYSTINURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0029916573     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpme.1996.24.2.119     Document Type: Review

References (138)

1. ABRAMS J: Interactions Between Organic Nitrates and Thiol Groups. Am J Med 91 (suppl 3C) (1991) 106S
2. AHOKAS RA, BM MERCER, BM SIBAI: Enhanced endothelium-derived relaxing factor activity in pregnant spontaneously hypertensive rats. Am J Obstet Gynecol 165 (1991) 801
3. ASSCHE VAN FA, B SPITZ, JT VERMYLEN, H DECKMIJN: Preliminary observations on treatment of pregnancy-induced hypertension with a thromboxane synthetase inhibitor. Am J Obstet Gynecol 148 (1984) 216
4. BAKER AB: Management of severe pregnancy-induced hypertension, or gestosis, with sodium nitroprusside. Anaesth Intensive Care 18 (1990) 361
5. BOLTE AC, GA DEKKER, J EYCK VAN, RJM STRACK VAN SCHIJNDEL, A VRIES DE, HP GEIJN VAN: Comparison of the effectively and safety of ketanserin versus dihydralazine in the treatment of severe preeclampsia (Abstract no 42, IXth ISSHP World Congress, March 1994, Sydney) In: Hypertension in Pregnancy Vol. 13 1994
6. BRENNECKE SP, NM GUDE. JL DILULIO, RG KING: Nitric oxide synthase activity in human placental villous tissue is reduced in pre-eclampsia (Abstract no 1, IXth ISSHP World Congress, March 1994, Sydney) In: Hypertension in Pregnancy 1994 in Vol. 13
7. BRESADOLA M, E MARINONI, S HORVATH, G MANZARI, FM PULCINELLI, PP GAZZANIGA, R DI IORIO: Use of a thromboxane receptor inhibitor in pregnancy-induced hypertension. Exper Models in Obstet Gynecol 1 (1990) 89
8. BUREN VAN GA, D YANG, KE CLARK: Estrogen-induced uterine vasodilatations is antagonized by L-nitroginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167 (1992) 828
9. CAMERON IT, CL PAPENDORP VAN, RMJ PALMER, SK SMITH, S MONCADA: Relationship Between Nitric Oxide Synthesis and Increase in Systolic Blood Pressure in Women with Hypertension in Pregnancy. Hypertension in Pregnancy 12 (1993) 85
10. CAPETTA P, ML AIROLDI, A TASCA, C BERTULESSI, F POLVANI: Prevention of pre-eclampsia and placental insufficiency. Lancet i (1986) 919
11. 2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol 265 (1993) H2036
12. CLARKE R, L DALY, K ROBINSON, E NAUGHTEN, S CAHALANE, B FOWLER, I GRAHAM: Hyperho mocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149
13. CLASP Collaborative Group: CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343 (1994) 619
14. GLERCK DE E, J BEETENS, D DE CHAFFOY DE COURCELLES, E FREYNE, PAJ JANSSEN: R 68070: Thromboxane A2 synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule I. Biochemical Profile in Vitro. Thromb Haemostas 61 (1989) 35
15. COCKS TM, JA ANGUS: Endothelium dependent relaxation of coronary arteries by noradrenaline and serotonine. Nature 305 (1983) 627
16. COLLER, P: Platelets and thrombolytic therapy. N Engl J Med 322 (1990) 33
17. CONRAD KP, MC COLPOYS: Evidence against the Hypothesis That Prostaglandins Are the Vasodepressor Agents of Pregnancy. J Clin Invest 77 (1986) 236
18. COTTON DB, S LONGMIRE, MM JONES, KP DORMAN, J TESSEM, TH JOYCE: Cardiovascular alterations in severe pregnancy-induced hypertension: Effects of intravenous nitroglycerin coupled with blood volume expansion. Am J Obstet Gynecol 154 (1986) 1053
19. COWCHOCK S: The role of Antiphospholipid Antibodies in Obstetric Medicine. Curr Obstet Mec 1 (1991) 229
20. DAVIDGE ST, TR BILLIAR, JM ROBERTS: Plasma nitrites and nitrates, stable end products of nitric oxide, are elevated in women with preeclampsia (Abstract no 60. IXth ISSHP World Congress, March 1994, Sydney) In: Hypertension in Pregnancy 1994 Vol. 13
21. DEKKER GA: Endothelial Dysfunction in Preeclampsia; Part I: Primary Prevention; Therapeutic Perspectives. J Perinat Med 24 (1996) 99
22. DEKKER GA, BM SIBAI: Early detection of preeclampsia. Am J Obstet Gynecol 165 (1991) 160
23. DEKKER GA, BM SIBAI: Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. Am J Obstet Gynecol 168 (1993) 214
24. DEKKER GA, HP VAN GEIJN: Second line therapy with Ketanserin in severe early-onset preeclampsia. In: COSMI EV, GC DI RENZO (eds): Hypertension in Pregnancy, Monduzzi Editore, Bologna, 1991
25. 2-synthetase in the treatment of pre gnancy-induced hypertension. In: COSMI EV, GC DI RENZO: Hypertension in Pregnancy, Monduzzi Editore, Bologna, 1991
26. DYERBERG J, HO BANG, N HJORNE: Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28 (1975) 958
27. DIJK VAN K, GA DEKKER, HP GEIJN VAN: Ritodrine and nifedipine as tocolytic agents. A preliminary comparision. J Perinat Med 23 (1995) 409
28. ELDER MG, L MYATT: First use of Nafazatrom, a new antithrombotic drug in pregnancy. Lancet i (1984) 1350
29. PICKLING SA, D WILLIAMS, P VALLANCE, SS NUSSEY, G ST J WHITLEY: Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 342 (1993) 242
30. FIDLER J, MJ BENNETT, M SWIET DE, C ELLIS, PJ LEWIS: Treatment of pregnancy hypertension with prostacyclin. Lancet ii (1980) 31
31. FITZGERALD DJ, SS ENTMAN, K MULLOY, GA FITZGERALD: Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 75 (1987) 956
32. FITZGERALD DJ, W ROCKI, R MURRAY, G MAYO, GA FITZGERALD: Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335 (1990) 751
33. FLORIJN KW, FHM DERKX, W VISSER, JA HOFMAN, FMA ROSMALEN, HCS WALLENBURG, MADH SCHALEKAMP: Plasma Immunoreactive Endothelin-1 in Pregnant Women With and Without Pre-eclampsia. J Cardiovasc Pharmacology 17 (Suppl 7) (1991) 446
34. FOX PL, PE DICORLETO: Endothelial Cell Production of Platelet-Derived Growth Factor. Seminars in Perinatology 15 (1991) 34
35. FRIED G, U SAMUELSON: Endothelin and neuropeptide Y are vasoconstrictors in human uterine blood vessels. Am J Obstet Gynecol 164 (1991) 1330
36. FRIEDMAN SA: Preeclampsia: A review of the role of Prostaglandins. Obstet Gynecol 71 (1988) 122
37. FURUHASHI N, M TSUJIEI M, H KIMURA, H NAGEA, A YAJIMA: Antithromboxane treatment affected plasma prostacylin and plasma thromboxane levels in severe preeclampsia. Int J Feto-Maternal Med 5 (1992) 63
38. GANT NF, GI DALEY, S CHAND, PJ WHALLEY, PC MACDONALD: A study of angiotensin-II pressor response throughout primigravid pregnancy. J Clin Invest 52 (1973) 2682
39. GARDINER SM, AM COMPTON, T BENNETT, RMJ PALMER, S MONCADA: Control of regional blood flow by endothelium-Derived Nitric Oxide. Hypertension 15 (1990) 486
40. GIBBONS GH, VJ DZAU: The emerging concept of vascular remodelling. N Engl J Med 330 (1994) 1431
41. GILES W, S O'CALLAGHAN, A BOURA, W WALTERS: Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitate. Lancet 340 (1992) 856
42. GOLIGORSKY MS, H TSUKAHARA, H MAGAZINE, TT ANDERSEN, AB MALIK, WF BAHOU: Termination of Endothelin Signaling: Role of Nitric Oxide. J Cell Physiol 158 (1994) 485
43. GREGORY CR, P HUIE, ME BILLINGHAM, RE MORRIS: Rapamycine inhibits arterial thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation 55 (1993) 1409
44. GRUNEWALD C, K CARLSTROM, M KUBLICKAS, N-O LUNELL, H NISELL, C SYLVEN: Nitroglycerin might improve umbilical circulation in preeclampsia (Abstract no 34, IXth ISSHP World Congress, March 1994, Sydney) In: Hypertension in Pregnancy Vol. 13 1994
45. HARKER LA, JM MARAGANORE, J. HIRSCH: Novel Antithrombotic Agents. In: COLMAN RW, J HIRSCH, VJ MARDER, EW SALZMAN: Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd edn, Lippincott, Philadelphia, 1994
46. HARKER LA: Platelets and vascular thrombosis. N Engl J Med 330 (1994) 1006
47. HAY DWP, DE GRISWOLD: Inhibitors of Fatty Acid-Derived Mediators. In: CUNNINGHAM FW (ed.): The Handbook of Immunopharmacology. Lipid Mediators, Academic Press, London, 1994
48. HERBERT JM, A TISSINIER, G DEFREYN, JP MAFFRAND: Inhibitory Effect of Clopidogrel on Platelet Adhesion and Intimal Proliferation After Arterial Injury in Rabbits. Arteriosclerosis and Thrombosis 13 (1993) 1171
49. HIRAFUJI M, Y ALIYAMA, T OGURA: Receptor-mediated stimulation of aortic prostacyclin release by 5-hydroxytryptamine. Eur J Pharmacol 143 (1987) 259
50. IGNARRO LJ: Biological actions and properties of Endothelium-Derived Nitric Oxide formed and released from artery and vein. Circulation Research 65 (1989) 1
51. IGNARRO LJ: Physiological Significance of Nitric Oxide. Seminars in Perinatology 15 (1991) 20
52. ISSELS RD, A NAGELE, KG ECKER, W WILMANNS: Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and n-acetylcysteine. Biochem Pharmacol 37 (1988) 881
53. JAFFE EA: Endothelial cells. In: GALLIN JI, IM GOLDSTEIN, RI SNYDERMAN: Inflammation: Basic Principles and Clinical Correlates, Raven Press, New York, 1988
54. JONG DE CLD, GA DEKKER, BM SIBAI: The renin-angiotensin-aldosterone system in preeclampsia; a review. Clinics in Perinatology 18 (1991) 683
55. JONG K DE, GA DEKKER, HP VAN GEIJN: The uteroplacental renin-angiotensin system in preeclampsia; a local circulatory rescue mechanism? Clin Exper Hyper - Hyper in Pregnancy 1993. Abstracts VIII World Congress International Society for the Study of Hypertension in Pregnancy, Buenos Aires, November 1992
56. JOUPPILA P, P KIRKINEN, A KOIVULA et al: Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia. Am J Obstet Gynecol 151 (1985) 661
57. KAMOI K, N SUDO, M ISHIBASHI, T YAMAJI: Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. N Engl J Med 323 (1990) 1486
58. KEITH JR JC, Y ENDO, K WARWICK et al: Effects of ridogrel on maternal/fetal homeostasis in an ovine model of preeclampsia. Hypertension in Pregnancy 12 (1993) 368
59. KEITH JR JC, TK ROWLES, S MISHRA, K DILORENZO, J KALNITSKY-ALIF, HP MISHRA: The cytotoxicity of preeclamptic sera can be attenuated by anti-TNF-alpha and ridogrel. Hypertension in Pregnancy 12 (1993) 270
60. 2 inhibitor, ozagrel, on the prevention of preeclampsia (Abstract 122, IXth ISSHP World Congress, March 1994, Sydney) In: Hypertension in Pregnancy Vol. 13 1994
61. KOHNO M, K YOKOKAWA, T HORIO, M IKEDA, N KURIHARA, AK MANDAL, T TAKEDA: Heparin inhibits endothelin-1 production in cultured mesangial cells. Kidney Int 45 (1994) 137
62. KOMORI K, H SHIMOKAWA, PM VANHOUTTE: Endothelium-Dependent Relaxation in Response to Aggregating Platelets in Porcine Femoral Veins and Its Modulation by Diet. Circulation 80 (1989) 401
63. KOUREMBANAS S, LP MCQUILLAN, GK LEUNG, DV FALLER: Nitric Oxide Regulates the Expression of Vasoconstrictors and Growth Factors by Vascular Endothelium under both Normoxia and Hypoxia. J Clin Invest 92 (1993) 99
64. KOWALA MC, CE MAZZUCCO, KS HARTL, SM SEILER, GA WARR, S ABID, RI GROVE: Prostacylin Agonists Reduce Early Atherosclerosis in Hyperlipidemic Hamsters. Octimibate and BMY 42393 Suppress Monocyte Chemotaxis, Macrophade Cholesteryl Ester Accumulation, Scavenger Receptor Activity, and Tumor Necrosis Factor Production. Arteriosclerosis and Thrombosis 13 (1993) 435
65. KRAAYENBRINK AA, GA DEKKER, GJ KAMP VAN, HP VAN GEIJN: Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 169 (1993) 160
66. KUBES P, M SUZUKI, DN GRANGER: Nitric oxide: An endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci 88 (1991) 4651
67. KUHN DC, B GOETZE-HUFF, JJ BOTTI, PH CHEROUNY, LM DEMERS: A stable prostacyclin analogue inhibits basal and stimulated thromboxane production in the placental villous core. In: COSMI EV, GC DI RENZO: Hypertension in Pregnancy, Monduzzi Editore, Bologna, 1991
68. LANG U, RS BAKER, KE CLARK: Fetal cardiovascular responses to maternal and fetal serotonin administration. Am J Obstet Gynecol 170 (Suppl) (1994) 264
69. LAHERA V, AA KHRAIBI, JC ROMERO: Sulfhydryl Group Donors Potentiate the Hypotensive Effect of Acetylcholine in Rats. Hypertension 22 (1993) 156
70. LEAF A, PC WEBER: Cardiovascular Effects of n-3 Fatty Acids. N Engl J Med 318 (1988) 549
71. LEWIS PJ, GL SHEPHERD, J RITTER et al: Prostacyclin and pre-eclampsia. Lancet i (1981) 599
72. LONGMIRE S, L LEDUC, MM JONES, JL HAWKINS, TH JOYCE III, DB COTTON: The hemodynamic effects of intubation during nitroglycerin infusion in severe pre-eclampsia. Am J Obstet Gynecol 164 (1991) 551
73. LOSCALZO J, AI SCAFER: Anticoagulants, Antiplatelet Agents, and Fibrinolytics. In: LOSCALZO J, MA CREAGER, VJ DZAU: Vascular Medicine, Little Brown, Boston, 1992
74. LOWENSTEIN CJ, JL DINERMAN, SH SNYDER: Nitric Oxide: A Physiologic Messenger. Ann Intern Med 120 (1994) 227
75. LUSCHER TF: Do we need endothelin antagonists? Cardiovascular Research 27 (1993) 2089
76. MALO-RANTA U, SY HERTTUALA, T METSA-KETELA, O JAAKKOLA, E MOILANEN, P VUORIXEN, T NIKKARI: Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Letters 337 (1994) 179
77. MIDDELKOOP CM, GA DEKKER, AA KRAAYENBRINK, C POPP-SNIJDERS: Platelet-Poor Plasma Serotonin in Normal and Preeclamptic Pregnancy. Clin Chem 39 (1993) 1675
78. MILLER KW, JC KEITH: Effect of Thromboxane Synthetase Inhibition on Platelet Function and Morphology During Ovine Pregnancy-Induced Hypertension. Thromb Haemostas 60 (1988) 365
79. MITCHELL MD: Endothelins in Perinatal Biology. Seminars in Perinatology 15 (1991) 79
80. MIYAUCHI T, Y TOMOBE, R SHIBA et al: Involvement of Endothelin in the Regulation of Human Vascular Tonus, Potent Vasoconstrictor Effect and Existence in Endothelial Cells. Circulation 81 (1990) 1874
81. MODDLEY J, E GOUWS: A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy. Br J Obstet Gynaecol 99 (1992) 727
82. MORAN N, GA FITZGERALD: Mechanisms of Action of Antiplatelet Drugs. In: COLMAN RW, J HIRSCH, VJ MARDER, EW SALZMAN: Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd edn, Lippincott, Philadelphia, 1994
83. MORETTI MM, FM FAIRLIE, S AKL, AD KHOURY, BM SIBAI: The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term. Am J Obstet Gynecol 163 (1990) 1844
84. MOUSA SA, JM BOZARTH, FS FORSYTHE, SM JACKSON, A LEAMY, MM DIEMER, RP KAPIL, RM KNABE, MC MAYO, SK PIERCE, WF DE GRADO, MJ THOOLEN, TM REILLY: Antiplatelet and Antithrombotic Efficacy of DMP 728, a Novel Platelet GPIIb/IIIa Receptor Antagonist. Circulation 89 (1994) 3
85. MURAD F: Cyclic Guanosine Monophosphate as a Mediator of Vasocilation. J Clin Invest 78 (1986) 1
86. MYATT L, A BREWER, DE BROCKMAN: The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164 (1991) 687
87. MYATT L, A BREWER, G LANGDON, DE BROCKMAN: Attenuation of the vasoconstrictor effects of thromboxane and endothelian by nitric oxide in the human fetal-placental circulation. Am J Obster Gynecol 166 (1992) 224
88. NEWBY AC, SJ GEORGE: Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc Res 27 (1993) 1173
89. NOVA A, BM SIBAI, JR BARTON, BM MERCER, MD MITCHELL: Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165 (1991) 724
90. OKAMOTO S, M INDEN, M SETSUDA, T KONISHI, T NAKANO: Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 123 (1992) 1439
91. OLIVA FA, E MAZZATENTA, E SALTARELLI, GD D'ANTONIO: The use of a selective thromboxane-synthetase inhibitor in the prevention of pregnancy toxemia and intrauterine growth retardation. G Ital Ostet Ginecol 13 (1991) 187
92. OLSEN SF, NJ SECHER: A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br J Nutr 64 (1990) 599
93. OLSEN SF, J OLSEN, G FRISCHE: Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy. Int J Epid 19 (1990) 971
94. PALMER RMJ, AG FERRIGE, S MONCADA: Nitric Oxide release accounts for the biological activity of Endothelium-Derived Relaxing Factor. Nature 327 (1987) 524
95. PANZA JA, AA QUYYUMI, JE BRUSH, SE EPSTEIN: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323 (1990) 22
96. PATTISON NS, LW CHAMLEY, EJ MCKAY, GC LIGGINS, WS BUTLER: Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 100 (1993) 909
97. PINTO A, R SORRENTINO, P SORRENTINO, T GUERRITORE, L MIRANDA, A BIONDI, P MARTINELLI: Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 164 (1991) 507
98. RADOMSKI MW, RMJ PALMER, S MONCADA: Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. TiPS 12 (1991) 87
99. RINDER CS, LA STUDENT, JL BONAN, HM RINDLER, BR SMITH: Aspirin Does Not Inhibit Adenosine Diphosphate-Induced Platelet alpha-Granule Release. Blood 82 (1993) 505
100. ROBERTS JM, RN TAYLOR, A GOLDFIEN: Endothelial Cell Activation as a Pathogenetic Factor in Preeclampsia. Seminars in Perinatology 15 (1991) 86
101. ROSAYRO DE M, ML NAHRWOLD, AB HILL et al: Plasma levels and cardiovascular effects of nitroglycerin in pregnant sheep. Can Anaesth Soc J 27 (1980) 560
102. ROSS R: The pathogenesis of atherosclerosis: an update. N Engl J Med 314 (1968) 488
103. 2 synthesis in pregnancy by polyunsaturated fatty acid supplements. Am J Obstet Gynecol 168 (1993) 122
104. SCHINI VB, S CATOVSKY, B SCHRAY-UTZ, R BUSSE, PM VANHOUTTE: Insulin-like Growth Factor I Inhibits Induction of Nitric Oxide Syn-thase in Vascular Smooth Muscle Cells. Circ Res 74 (1994) 24
105. SCHULZ E, F RUSCHITZKA, S LUDERS, W RATH, J SCHRADER: Endothelin-induced vasoconstriction and hyper-coagulability and its prevention by hirudin (Abstract 23, IXth ISSHP World Congress, March 1994, Sydney) In: Hypertension in Pregnancy Vol. 13 1994
106. SELIGMAN SP, SB ABRAMSON, BK YOUNG, JP BUYON: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 170 (Suppl) (1994) 290
107. SIBAI BM, JR BARTON, S AKL, C SARICOGLU, BM MERCER: A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 167 (1992) 879
108. SIBAI BM, SN CARITIS, E THOM et al: Prevention of Preeclampsia With Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women. N Engl J Med 329 (1993) 1213
109. SIEGFRIED MR, J ERHARDT, T RIDER, XL MA, AM LEFER: Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 20 (1992) 668
110. SIGMON DH, WH BEIERWALTES: Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am J Physiol 1993; 265 (1993) R1276
111. SILVER HM: Acute hypertensive crisis in pregnancy. Med Clin North Am 73 (1989) 623
112. SILVER RK, N SCOTT, DO MACGREGOR, JS SHOLL, JM HOBART, MG NEERHOF, A RAGIN: Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antobidy-positive obstetric patients. Am J Obstet Gynecol 169 (1993) 1411
113. SILVER RM, C COULAM, JL LYON, RJ SCOTT, DW BRANCH: Clinical consequences of low positive IgG anticardiolipin antibodies. Am J Obstet Gynecol 170 (Suppl): (1994) 336
114. SORENSEN JD, SF OLSEN, AK PEDERSEN, J BORIS, NJ SECHNER, GA FITZGERALD: Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol 168 (1993) 915
115. SPITZ B, P VAN BREE, G VAN BALLAER, M HANSSENS, F VAN ASSCHE: Differential inhibition of vascular prostacyclin and platelet thromboxane synthesis by different doses aspirin and by the thromboxane inhibitor ridogrel (R 68070). Clin Exper Hyper - Hyper in Pregnancy B10 (1991) 371
116. STEEGERS-THEUNISSEN RPM, GHJ BOERS, JMF TRUBELS, TKAB ESKES: Hyperhomocysteïnemia and recurrent abortion or abruptio placentae. Lancet 339 (1992) 1122
117. STEEL SA, JM PEARCE: Specific therapy in severe fetal growth retardation: failure of prostacyclin. Journal of the Royal Society of Medicine 81 (1988) 214
118. 2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs. Cardiovasc Res 27 (1993) 1374
119. TAYLOR RN, M VARMA, NH TENG, JM ROBETS: Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71 (1990) 1675
120. TAYLOR RN, DC HEILBRON, JM ROBERTS: Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol 163 (1990) 1839
121. The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa in high-risk coronary angioplasty. N Engl J Med 330 (1994) 956
122. 1 or dihydralazine infusions. Am J Obstet Gynecol 164 (1991) 1229
123. TOTANI L, A PICOLLI, G PELLEGRINI, A DI SANTO, R LORENZET: Polymorphonuclear Leucocytes Enhance Release of Growth Factors by Cultured Endothelial Cells. Arterioscler Thromb 14 (1994) 125
124. VANE JR: The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation. Phil Trans R Soc London 343 (1994) 225
125. VANHOUTTE PM: Serotonergic antagonists and vascolar disease. Cardiovasc Drugs Ther 4 (1990) 7
126. VAUGHAN WG, JW HORTON, DJ WHITE: Burn induced cardiac dysfunction is reduced by pentoxifyllme. Surg Gynecol Obstet 176 (1993) 459
127. WALSH SW: Lipid peroxidation in pregnancy. Hypertension in Pregnancy 13 (1994) 1
128. WARD A, SP CLISSOLD: Pentoxifylline. A Review of its Pharmacodynamic and Pharmacokinetic Properties, and its Therapeutic Efficacy. Drugs 34 (1987) 50
129. WARE BRANCH D, GM RODGERS: Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: A possible mechanism of thrombosis. Am J Obstet Gynecol 168 (1993) 206
130. WASSERSTRUM N: Nitroprusside in Preeclampsia: Circulatory Distress and Paradoxical Bradycardia. Hypertension 18 (1991) 79
131. WEINER CP: Serotonin and the Preeclampsia - Eclampsia Syndrome. In: Serotonin and the Cardiovascular System. Raven Press New York, 1985
132. WEINER CP: The role of serotonin in the genesis of hypertension in preeclampsia. Am J Obstet Gynecol 4 (1987) 885
133. WEINER CP: The role of serotonin in the preeclampsia/eclampsia syndrome. Cardiovascular Drugs and Therapy 4 (1990) 37
134. WEISSBERG PL, DJ GRAINGER, CM SHANAHAN, JC METCALFE: Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. Cardiovasc Res 27 (1993) 1191
135. WHEELER AS, FM JAMES III, PJ MEIS et al: Effects of nitroglycerin and nitroprusside on the uterine vasculature of gravid ewes. Anesthesiology 52 (1980) 390
136. WOUTERS MGAJ, GHJ BOERS, HJ BLOM, FJM TRUBELS, CMG THOMAS, GF BORM, RPM STEEGERS-THEUNISSEN, TKAB ESKES: Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertility and Sterility 60 (1993) 820
137. WU G, CJ MEININGER: Regulation of L-arginine synthesis from L-citrulline by L-glutamine in endothelial cells. Am J Physiol 265 (1993) H1965
138. ZEEMAN GG, GA DEKKER: Pathogenesis of Preeclampsia: A Hypothesis. Clin Obstet Gynecol 35 (1992) 317